-
公开(公告)号:GB0913558D0
公开(公告)日:2009-09-16
申请号:GB0913558
申请日:2008-05-30
Applicant: ACADEMIA SINICA
Abstract: A conserved cluster of oligomannose glycans on gp120 has been identified as the epitope recognized by the broadly HIV-1-neutralizing monoclonal antibody 2G12. Oligomannose glycans are also the ligands for DC-SIGN, a C-type lectin found on the surface of dendritic cells. Multivalency is fundamental for carbohydrate-protein interactions, and mimicking of the high glycan density on the virus surface has become essential for designing carbohydrate-based HIV vaccines and antiviral agents. Synthesis of oligomannose dendrons, which display multivalent oligomannoses in high density, and characterize their interaction with 2G12 and DC-SIGN by a glycan microarray binding assay is disclosed. These glycodendrons inhibit the binding of gp120 to 2G12 and recombinant dimeric DC-SIGN with IC50 in the nanomolar range. A second-generation Man9 dendron was identified as a potential immunogen for HIV vaccine development and as a potential antiviral agent.
-
公开(公告)号:CA2678013A1
公开(公告)日:2008-08-21
申请号:CA2678013
申请日:2008-02-12
Applicant: ACADEMIA SINICA , UNIV NAT TAIWAN
Inventor: LIN CHIN-TARNG , WU HAN-CHUNG , CHANG DE-KUAN
Abstract: The invention provides nucleic acids, peptides, and antibodies for use in applications including diagnosis and therapy. The peptides target lung canc er and were identified by phage display. Targeting phage PC5-2 and synthetic peptide SP5-2 were both able to recognize human pulmonary tumor specimens f rom lung cancer patients. In SCID mice bearing NSCLC xenografts, the targeti ng phage was able to target tumor masses specifically. When the peptide was coupled to liposomes containing the anti-cancer drugs vinorelbine or doxorub icin, the efficacy of these drugs against human lung cancer xenografts was i mproved, the survival rate increased, and the drug toxicity was reduced.
-
公开(公告)号:GB0809919D0
公开(公告)日:2008-07-09
申请号:GB0809919
申请日:2008-05-30
Applicant: ACADEMIA SINICA
Abstract: A conserved cluster of oligomannose glycans on gp120 has been identified as the epitope recognized by the broadly HIV-1-neutralizing monoclonal antibody 2G12. Oligomannose glycans are also the ligands for DC-SIGN, a C-type lectin found on the surface of dendritic cells. Multivalency is fundamental for carbohydrate-protein interactions, and mimicking of the high glycan density on the virus surface has become essential for designing carbohydrate-based HIV vaccines and antiviral agents. Synthesis of oligomannose dendrons, which display multivalent oligomannoses in high density, and characterize their interaction with 2G12 and DC-SIGN by a glycan microarray binding assay is disclosed. These glycodendrons inhibit the binding of gp120 to 2G12 and recombinant dimeric DC-SIGN with IC50 in the nanomolar range. A second-generation Man9 dendron was identified as a potential immunogen for HIV vaccine development and as a potential antiviral agent.
-
公开(公告)号:CA2678051A1
公开(公告)日:2008-02-21
申请号:CA2678051
申请日:2008-02-12
Applicant: ACADEMIA SINICA , UNIV NAT TAIWAN
Inventor: WU HAN-CHUNG , LIN CHIN-TARNG , LEE TONG-YOUNG , KUO SZU-YAO
Abstract: The invention provides nucleic acids, peptides, and antibodies for use in applications including diagnosis and therapy. The peptides target neovascul ature and were identified by in vivo phage display. One such peptide, SP5-52 , recognized the neovasculature of multiple tumors in SCED mice, but did not target normal blood vessels. This peptide also binds to blood vessels of hu man lung cancer biopsy specimens. Liposomes comprising SP5-52 and doxorubici n enhanced the efficacy of the drug against multiple human cancer xenografts in SCED mice.
-
公开(公告)号:CA2651954A1
公开(公告)日:2007-11-22
申请号:CA2651954
申请日:2007-05-11
Applicant: ACADEMIA SINICA , PHARMIGENE INC
Inventor: CHEN WEI-HSUAN , LIN HSIN-YU , CHANG CHI-FENG , SHEN CHIH-LUNG , HUNG SHUEN-LU , CHEN YUAN-TSONG
Abstract: This invention relates to a method of determining the presence of certain HLA alleles, such as HLA-B*1502 or HLA-B*5801, and a kit for carrying out t his method. Also disclosed is a method for assessing whether a patient is at risk for developing adverse drug reactions (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis, or hypersensitivity syndrome) based on the pres ence or absence of a genetic marker (e.g., HLA-B*1502, HLA-B*5801, or HLA-B* 4601).
-
公开(公告)号:CA2591840A1
公开(公告)日:2006-06-29
申请号:CA2591840
申请日:2005-12-21
Applicant: ACADEMIA SINICA
Inventor: CHENG YAUN-TSONG , YUAN HSIANG-YU , CHEN JIN-JER
IPC: C12Q1/68
Abstract: We discovered that a polymorphism in the promoter of the VKORCI gene is associated with warfarin sensitivity. This polymorphism can explain both the interindividual and inter-ethnic differences in warfarin dose requirements. Furthermore, the polymorphism is also associated with promoter activity. Thus, the promoter sequence or activity of the VKORCI gene of a subject can be used to predict how much warfarin should be prescribed for the subject. Relevant methods and compositions are provided.
-
公开(公告)号:DE69829824T2
公开(公告)日:2006-01-12
申请号:DE69829824
申请日:1998-08-24
Applicant: ACADEMIA SINICA TAIPEH T AI PE
Inventor: YU SU-MAY , CHAN MING-TSAIR
Abstract: An expression vector comprising a promoter capable of directing expression of a coding sequence in an angiosperm cell, and a 3' untranslated region of a rice alpha -amylase gene, wherein, after the coding sequence is inserted into the vector, the 3' untranslated region and the coding sequence are transcribed into a single mRNA. Also featured are methods of producing a polypeptide in angiosperm cells using such a vector.
-
公开(公告)号:DE69829824D1
公开(公告)日:2005-05-25
申请号:DE69829824
申请日:1998-08-24
Applicant: ACADEMIA SINICA TAIPEH T AI PE
Inventor: YU SU-MAY , CHAN MING-TSAIR
Abstract: An expression vector comprising a promoter capable of directing expression of a coding sequence in an angiosperm cell, and a 3' untranslated region of a rice alpha -amylase gene, wherein, after the coding sequence is inserted into the vector, the 3' untranslated region and the coding sequence are transcribed into a single mRNA. Also featured are methods of producing a polypeptide in angiosperm cells using such a vector.
-
公开(公告)号:AU2003244587A1
公开(公告)日:2005-01-27
申请号:AU2003244587
申请日:2003-07-14
Applicant: ACADEMIA SINICA
Inventor: YANG NING-SUN , SHYUR LIE-FEN , WANG SHENG-YANG , SUN SHOW-JANE , KANG PEI-LING
-
公开(公告)号:NO20040966L
公开(公告)日:2004-04-22
申请号:NO20040966
申请日:2004-03-05
Applicant: ACADEMIA SINICA
Inventor: HUEY-LANG YANG , YU JAMES CHEIN-CHIH , LIN JOHN HAN-YOU
IPC: A61K39/00 , A01N63/16 , A01N63/20 , A61K39/02 , A61K39/104 , A61K47/00 , A61P31/04 , C12N15/09 , C12N15/63
Abstract: This invention features an oral vaccine that includes a multiple-cell organism for use as food for an aquatic animal to be vaccinated, and a single-cell organism fed to, and as a result, bioencapsulated by, the multiple-cell organism. The single-cell organism has been transformed to express a recombinant antigen that induces an immune response in the aquatic animal and thereby vaccinates the aquatic animal (e.g., a fish or a shrimp).
-
-
-
-
-
-
-
-
-